Our MBTA Car Cards for our upcoming public, free Breast Cancer Symposium on January 28th are ready!!! Bostonians, look out for these posters on the T's - take a picture and send it to us. :) 

Thank you Genentech, MBTA, The Print House, Life Alive, The Body Shop-Harvard Square, and Iggy's Bread for your sponsorship and continuous support!

Join our FREE and PUBLIC Breast Cancer Symposium - register for free! Space is limited!

http://www.cancerresearchsimplified.org/crs-breast-cancer-symposium.html

‪#‎Boston‬ ‪#‎Cambridge‬ ‪#‎Somerville‬ ‪#‎Massachusetts‬ ‪#‎BreastCancer‬‪ #‎BreastCancerSymposium‬ ‪#‎FreeBreastCancerSymposium‬ #FreePublicBreastCancerSymposium

Singer Joe Cocker dies at age 70 after battling Lung Cancer.  Lung cancer remains to be the #1 of all cancer deaths WORLDWIDE!  According to the National Institute of Health, National Cancer Institute, in 2014, it is estimated that there will be 224,210 new cases of lung and bronchus cancer and an estimated 159,260 people will die of this disease.

R.I.P. Joe Cocker, you will never be forgotten! 

Read the full article here:
http://www.bbc.com/news/entertainment-arts-30582761

****STUDY: Study linked decreased survival of Glioblastoma multiforme (GBM) patients with long-term use of mobile and cordless phones

In this study, scientists from Sweden have analyzed the association between use of mobile and cordless phones and glioma. The survival analysis was conducted with 1678 glioma patients in their case-control studies between 1997–2003 and 2007–2009. They have found elevated hazard ratio (HR) in astrocytoma grade IV, a.k.a. Glioblastoma multiforme (GBM), the most aggressive, most invasive, deadly type of adult brain cancer. Highest HR was found for cases with first use of wireless phones before the age of 20 years. The least affected group was low-grade astrocytomas. Nevertheless, the scientists have reported increased risk for both low-grade (grade I–II) and high-grade astrocytoma (grade III–IV) associated with use of mobile and cordless phones. 

#Glioblastomamultiforme #GBM #braincancer #braintumor #cancer #cancerawareness #cancerrisk #environmentalfactorsandcancer #mobilephonesandcancer #mobilephones #cordlessphonesandcancer #mobilephonesandbraincancer #mobilephonesandbraintumor #canceredinstitute

For immediate release

December 17, 2014

Cancer Research Simplified Appoints New Board Members

Somerville, MA….Today, Cancer Research Simplified announced its newest board members, Claudia Bertuccio, Ph.D, and Mr. Mike Ryan, whom have been appointed at the Board meeting on October 20, 2014, and Ewa Wybieralaska, Ph.D., who was appointed at the Board meeting on December 15, 2014. These new board members have been appointed to help spearhead Cancer Research Simplified’s phenomenal growth in its research and fundraising activities, according to Dr. Ayguen Sahin, CEO and Founder of Cancer Research Simplified. “We are pleased to have all of these remarkable individuals on the Board,” says Dr. Sahin,  “Our goal is to bring everyone’s outstanding skills to the table along with our amazing volunteers to further develop our ‘simplified’ cancer education programs, already highly sought after worldwide.” 

Dr. Wybieralaka, Dr. Bertuccio, and Mr. Ryan have been diligently working for CRS over the past year, with extensive involvement in all CRS activities, including determining funding, writing for CRS’s official journal, the Journal of Simplified Cancer Research (JSCR), organizing the upcoming 2015 Cancer Symposium Series, and coordinating press and media relations.

All have contributed to spreading CRS’s mission throughout the world, resulting in 35,762 amount of hits on the website and 11,103 amount of hits on Youtube, writing and editing the Journal of Simplified Cancer Research, producing large number of ‘daily’ educational pictures, organizing many fundraisers, sports and recreation events, and securing important grants, such as the most recent one from Genentech (see September 25, 2014 press release).

About the three new board members:

Claudia Bertuccio, Ph.D.           Director, Research Team Member, and Spanish Translator 
Dr. Bertuccio received her B.Sc. and PhD degree in Biological Sciences and Physiology, respectively, from the University of Buenos Aires, Argentina. She worked as a postdoctoral fellow and Research Associate in the School of Medicine at Yale University and the University of Pittsburgh. During her postdoctoral studies she developed an extensive background in Cellular and Molecular Biology, studying the signaling pathways responsible for metabolic human diseases and identifying intracellular molecules that can be used in therapeutic strategies. During her scientific career, she won several awards and fellowships from CONICET, National Kidney Foundation Research, and James Hudson Brown - Alexander B. Coxe Foundation. She has been invited as speaker at several scientific meetings. She had the opportunity to teach Cellular/Molecular Biology, Physiology, Physiopathology and Histology courses in different prestigious Universities in Argentina and won the Young Investigator Educational Enhancement Award at the University of Buenos Aires. In the past, she also gained experience in clinical research trials doing an internship at MAT & Asociados, Clinical Research Organization and collaborating in a clinical research of Merck Laboratories in Buenos Aires, Argentina. She is fluent in English and Spanish.

Ewa Wybieralska, Ph.D.      Director, Events Coordinator
Dr. Wybieralska is a practicing academic scientist with 10 years’ experience in molecular and cellular biology. She received her MSc and PhD degrees from Jagiellonian University in Poland. She completed some of her work at the Centre de Biophysique Moleculaire, in Orleans, France, the Institute of Biochemistry and Molecular Biology, University of Wroclaw, Poland and Nencki Institute of Experimental Biology, Polish Academy of Sciences. Currently she is a postdoctoral fellow at the Departments of Anesthesia and Medicine at Brigham and Women’s Hospital, Harvard Medical School in Boston and a member of the American Heart Association. Her research focuses on the factors determining cancer metastasis with a special attention to cancer cell migration. She worked on human melanoma, prostate and breast cancer cells, and most recently, cardiac primary tumors and metastases. She is an author of several scientific papers and abstracts presented at international conferences. 

Michael E. Ryan                    Director, Public Relations and Development Manager
Mr. Ryan has over 18 years of experience in sales in international business-to-business communications. He most recently served for seven years as the Assistant Director of Sales for the Association for Research in Vision and Ophthalmology (ARVO), the largest association for eye and vision research in the field. He excelled at bringing research scientists together with industry by engaging both parties via exhibitions, publications and interactive means. He is a featured speaker at healthcare events, and a fighter for global wellness.

Cancer Research Simplified has announced its call for new Board member applications. Application form can be filled on online its website http://www.cancerresearchsimplified.org/board-member-application.html. CRS accepts applications until December 23, 2014.    

 -30-

About Cancer Research Simplified:
Cancer Research Simplified™ is a non-profit organization, committed to providing ‘simplified’ information resources to cancer patients about their disease, the latest cancer research, and cancer institutes and hospitals worldwide that provide specialized cancer care and specific targeted therapy methods. In addition, we provide scholarships for high school students worldwide to perform research activities at renowned cancer research institutions around the world.

Mission Statement
Making cancer research understandable for everyone. Providing scholarships for young students worldwide to encourage careers in cancer research.  

Vision
By providing cancer patients with information about their disease, up-to-date research, and specialized cancer treatment institutes, we can bridge the gap between cancer patients and cancer-treatment professionals and ease the burden on cancer patients by making it easy to find the best possible care.

Contact Mike Ryan, at [email protected] for further information.

All you need to know about clinical trials - Part II: What is the informed consent process? 

6. What happens next when you sign the informed consent form

To read the full article about the informed consent, download our official journal, the Journal of Simplified Cancer Research (JSCR), October 2014 issue: http://www.cancerresearchsimplified.org/journal-of-simplified-cancer-research-jscr.html 

Thank you for liking and sharing with others! 

#Cancer #clinicaltrials #clinicaltrialsforcancer #journalofsimplifiedcancerresearch #jscr #cancersimplified

All you need to know about clinical trials - Part II: What is the informed consent process? 

5. The process before signing the informed consent form

To read the full article about the informed consent, download our official journal, the Journal of Simplified Cancer Research (JSCR), October 2014 issue: http://www.cancerresearchsimplified.org/journal-of-simplified-cancer-research-jscr.html 

Thank you for liking and sharing with others! 

#Cancer #clinicaltrials #clinicaltrialsforcancer #journalofsimplifiedcancerresearch #jscr #cancersimplified

All you need to know about clinical trials - Part II: What is the informed consent process? 

4. The process before signing the informed consent form

To read the full article about the informed consent, download our official journal, the Journal of Simplified Cancer Research (JSCR), October 2014 issue: http://www.cancerresearchsimplified.org/journal-of-simplified-cancer-research-jscr.html 

Thank you for liking and sharing with others! 

#Cancer #clinicaltrials #clinicaltrialsforcancer#journalofsimplifiedcancerresearch #jscr #cancersimplified

All you need to know about clinical trials - Part II: What is the informed consent process? 

3. What is an informed consent form?

To read the full article about the informed consent, download our official journal, the Journal of Simplified Cancer Research (JSCR), October 2014 issue: http://www.cancerresearchsimplified.org/journal-of-simplified-cancer-research-jscr.html 

Thank you for liking and sharing with others! 

#Cancer #clinicaltrials #clinicaltrialsforcancer #journalofsimplifiedcancerresearch #jscr #cancersimplified

"CANDY-FLAVORED" TOBACCO

Centers for Disease Control and Prevention were reports that flavored smoking product are used by 42% of middle-school and high school students who smoke. Some authorities, such as New York City and Providence, RI have passed some restrictions. 

A 2007 World Health Organization (WHO) report states, “In view of the little research that has been conducted on flavoured tobacco, the WHO Study Group on Tobacco Product Regulation urges …. health authorities to consider public health initiatives to reduce the marketing and use of flavoured tobacco products.”

In the United States, the Food and Drug Administration reports, “Almost 90 percent of adult smokers start smoking as teenagers …. flavored cigarettes are a gateway for many children and young adults to become regular smokers.” 

A study, published in NEJM, in May 2014, led by Professor James F. Pankow, Ph.D. (elected to Prestigious National Academy of Engineering) at the Portland State University, Portland, identified the flavor chemicals and their levels in several brands of candy, Kool-Aid drink mix, and similarly labeled “cherry”, “grape”, “apple”, “peach”, and “berry” tobacco products. 

#tobacco #candyflavoredtobacco #candy #chemicals #chemicalsinfood #health #lungcancer #smoking #teenagers #teeneragersandsmoking #quitsmoking #stopsmoking #cancer #cancereducation #cancerawareness #cancersimplified